DIABNEXT

📍 Paris, France👥 4 employees💰 Last funded Jun 2018
Wellness and Fitness Services🌐 diabnext.com
Website LinkedIn
DIABNEXT was founded with the vision of developing highly innovative solutions that help people with diabetes better manage their chronic condition and improve their care and quality of life. Through collaboration with many leaders and clinicians in diabetes healthcare, the DIABNEXT platform offers patients a unique solution that enables remote monitoring, coordination, therapeutic education and analytics of data related to blood glucose, insulin, diet and physical activity automatically through connected health devices. DIABNEXT was acquired by Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, in March 2022. The DIABNEXT platform is now marketed under the name Glooko XT.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in DIABNEXT?
DIABNEXT has 1 investors on record on gritt.io.
When did DIABNEXT last raise funding?
The most recent investment in DIABNEXT recorded on gritt.io was in June 2018.
What industry is DIABNEXT in?
DIABNEXT operates in Wellness and Fitness Services. Find similar Wellness and Fitness Services investors on gritt.io.
Where is DIABNEXT based?
DIABNEXT is headquartered in Paris, France.